Vega, Jellian .
HRN: 29-19-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
CEFUROXIME 500MG (TAB)
07/17/2026
07/24/2026
PO
500mg
BID
Thinly MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes